Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
NDC Package 70710-1986-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Sitagliptin And Metformin Hydrochloride tablets is classified as a

administered via oral route. This formulation utilizes a tablet, film coated delivery system. Marketed by Zydus Pharmaceuticals (usa) Inc., this product is identified by NDC 70710-1986 and is authorized under FDA application NDA216743.

Identification & Billing

NDC Package Code
70710-1986-8
Package Description
180 TABLET, FILM COATED in 1 BOTTLE
Product Code
70710-1986
11-Digit Billing Format
70710198608
RxNorm Crosswalk
  • RxCUI: 861769 - SITagliptin 50 MG / metFORMIN HCl 1000 MG Oral Tablet
  • RxCUI: 861769 - metformin hydrochloride 1000 MG / sitagliptin 50 MG Oral Tablet
  • RxCUI: 861819 - SITagliptin 50 MG / metFORMIN HCl 500 MG Oral Tablet
  • RxCUI: 861819 - metformin hydrochloride 500 MG / sitagliptin 50 MG Oral Tablet

Clinical Specifications

Proprietary Name
Sitagliptin And Metformin Hydrochloride
Non-Proprietary Name
Sitagliptin And Metformin Hydrochloride
Substance Name
Metformin Hydrochloride; Sitagliptin
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals (usa) Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA216743
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
03-14-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70710-1986). Click a package code to view its specific billing and regulatory data.

70710-1986-6
60 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1986-8 identifies a specific commercial package of 180 tablet, film coated in 1 bottle of Sitagliptin And Metformin Hydrochloride, a human prescription drug labeled by Zydus Pharmaceuticals (usa) Inc.. This tablet, film coated is formulated for oral use and contains metformin hydrochloride; sitagliptin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals (usa) Inc. on March 14, 2024. The current certification is valid through December 31, 2026.

How is this Zydus Pharmaceuticals (usa) Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710198608. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1986-8
11-Digit CMS (5-4-2)
70710-1986-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.